COLCHICINE : COVID-19 Trial Underway
COLCHICINE : COVID-19 Trial Underway

Researchers in the United States, Canada & Europe are testing Colchicine on approximately 6,000 participants for a period of 30 days.

The trial is to find out whether short-term treatment with colchicine will reduce lung complications and the rate of death in COVID-19 patients.

Colchicine is thought to decrease the ‘cytokine storm’ or inflammation that causes complications and death, in patients with COVID-19.

Colchicine has also currently been approved by FDA for gout and familial mediterranean fever.

Share this article
Share on facebook
Share on twitter
Share on linkedin
Your must go through these
View More Related Blogs
    Your Cart
    Your cart is emptyReturn to Shop
    Upload Test Report Form

    Any Query?